Clinical Research Directory
Browse clinical research sites, groups, and studies.
Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial
Sponsor: Shanghai Changzheng Hospital
Summary
This study is an exploratory clinical trial. It is intended to investigate the efficacy of mesenchymal stem cell-derived exosome nebulization in the treatment of postinfectious cough through a randomized controlled clinical study, with a view to providing better treatment options for patients with postinfectious cough, improving their quality of life, and providing reference data for the subsequent multi-center clinical trials.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-07-16
Completion Date
2025-12-30
Last Updated
2025-08-05
Healthy Volunteers
No
Conditions
Interventions
Mesenchymal stem cell derived exosome nebulization combined with compound methoxyphenamine capsule
Mesenchymal stem cell derived exosome nebulization (FITCELL 5ml nebulization QD) was combined with compound methoxyphenamine capsule ( "Asmei" 2 capsules oral TID) for cough treatment.
Normal saline nebulization combined with the compound methoxyphenamine capsule
Normal saline nebulization (0.9% sodium chloride 5ml nebulization QD) was combined with the compound methoxyphenamine capsule ("Asmei" 2 capsules oral TID) for cough treatment.
Locations (1)
Shanghai changzheng hospital
Shanghai, Shanghai Municipality, China